Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin.

Tobu, MHoppensteadt, DAChatha, MBansal, VMoghaddam, MSarfraz, ADemir, M2024-06-122024-06-1220030006-4971https://hdl.handle.net/20.500.14551/2668545th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2003 -- SAN DIEGO, CALIFORNIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin.Conference Object10211119B119BQ1WOS:000186537100478